M6A-Related Bioinformatics Analysis Reveals a New Prognostic Risk Signature in Cutaneous Malignant Melanoma

Figure 5

Gene set enrichment analysis of the three selected m6A regulators. (a) The top 15 nondisease-related pathways in the ELAVL1 high expression group. (b) The top 15 nondisease-related pathways in the ABCF1 high expression group. (c) The top 15 nondisease-related pathways in the IGF2BP1 high expression group. (d) Enriched gene sets in the first 6 enriched pathways in the ELAVL1 high expression group. (e) Enriched gene sets in the first 6 enriched pathways in the ABCF1 high expression group. (f) Enriched gene sets in the first 6 enriched pathways in the IGF2BP1 high expression group.

(a)

(b)

(c)

(d)

(e)

(f)